ProShare Advisors’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,090
| Closed | -$52K | – | 1815 |
|
|
2019
Q3 | $52K | Sell |
10,090
-302
| -3% | -$1.56K | ﹤0.01% | 1598 |
|
|
2019
Q2 | $64K | Sell |
10,392
-1,312
| -11% | -$8.08K | ﹤0.01% | 1563 |
|
|
2019
Q1 | $83K | Buy |
11,704
+93
| +0.8% | +$660 | ﹤0.01% | 1585 |
|
|
2018
Q4 | $99K | Sell |
11,611
-2,166
| -16% | -$18.5K | ﹤0.01% | 1474 |
|
|
2018
Q3 | $276K | Sell |
13,777
-458
| -3% | -$9.18K | ﹤0.01% | 1407 |
|
|
2018
Q2 | $368K | Sell |
14,235
-356
| -2% | -$9.2K | ﹤0.01% | 1266 |
|
|
2018
Q1 | $349K | Buy |
14,591
+101
| +0.7% | +$2.42K | ﹤0.01% | 1254 |
|
|
2017
Q4 | $491K | Buy |
14,490
+801
| +6% | +$27.1K | ﹤0.01% | 1140 |
|
|
2017
Q3 | $290K | Buy |
13,689
+918
| +7% | +$19.4K | ﹤0.01% | 1150 |
|
|
2017
Q2 | $223K | Sell |
12,771
-1,010
| -7% | -$17.6K | ﹤0.01% | 1295 |
|
|
2017
Q1 | $241K | Sell |
13,781
-3,424
| -20% | -$59.9K | ﹤0.01% | 1358 |
|
|
2016
Q4 | $291K | Buy |
17,205
+1,739
| +11% | +$29.4K | ﹤0.01% | 1384 |
|
|
2016
Q3 | $254K | Sell |
15,466
-2,672
| -15% | -$43.9K | ﹤0.01% | 1217 |
|
|
2016
Q2 | $275K | Buy |
18,138
+794
| +5% | +$12K | ﹤0.01% | 1246 |
|
|
2016
Q1 | $251K | Buy |
17,344
+1,017
| +6% | +$14.7K | ﹤0.01% | 1292 |
|
|
2015
Q4 | $462K | Buy |
+16,327
| New | +$462K | 0.01% | 1067 |
|